Stigma-Free Health Care in New England

Long-acting Injectable HIV Treatment: Revolutionizing HIV Care

Long-acting Injectable HIV Treatment: Revolutionizing HIV Care

Long-acting Injectable HIV Treatment: Revolutionizing HIV Care

The Evolution of HIV Treatment

The journey of HIV treatment has been nothing short of revolutionary, moving from the daily regimen of pills to the innovative long-acting injectable treatments. This evolution marks a significant milestone in the care and management of HIV, offering new hope and convenience for those living with the virus.

Understanding the Journey from Daily Pills to Injections

Initially, HIV treatment required consuming multiple pills daily, a regimen that could be challenging due to side effects, the complexity of schedules, and the stigma associated with taking HIV medication publicly. The development of long-acting injectable treatments, such as Cabenuva, has transformed this landscape, reducing the frequency of dosing to just once every two months.  FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV


The Role of Research in Advancing HIV Care

Behind this transformative shift lies years of rigorous research and clinical trials aimed at finding more effective, safer, and convenient treatment options for HIV. These efforts have not only improved the quality of life for many individuals but also highlighted the importance of continuous innovation in healthcare.

Milestones in HIV Treatment History

The history of HIV treatment has seen several key milestones, from the first antiretroviral drugs in the late 1980s to the introduction of combination therapies in the 1990s, which significantly improved life expectancy. The advent of long-acting injectables is the latest achievement in this ongoing journey.

From Apretude to Cabenuva: A Closer Look

Two notable long-acting injectables have made headlines: Apretude for HIV prevention and Cabenuva for HIV treatment. These medications represent a leap forward in making HIV care more accessible and less burdensome, showcasing the potential of long-acting formulations in chronic disease management.

How Long-acting Injectables Are Changing the Game

Long-acting injectables offer a game-changing approach to HIV treatment and prevention by enhancing adherence, reducing the stigma associated with daily pill consumption, and potentially decreasing the risk of viral resistance due to missed doses. They signify a move towards more personalized and less intrusive treatment options.

The evolution of HIV treatment from daily pills to long-acting injectables like Cabenuva exemplifies the remarkable progress in medical science and the ongoing commitment to improving the lives of those affected by HIV. At Pathway To Better Health, we’re at the forefront of adopting these advancements, ensuring our community has access to the latest and most effective HIV care options.

Benefits of Long-acting Injectable Treatment

The introduction of long-acting injectable treatments has transformed the landscape of HIV treatment. These medications have not only altered the management of HIV but have also delivered a host of benefits for individuals living with the virus.

Convenience and Compliance

The convenience of long-acting injectables can’t be overstated. With treatments like Cabenuva, which is administered only once a month or every two months, patients are relieved from the daily reminder of their condition. This convenience boosts compliance, as maintaining a treatment schedule becomes significantly easier.

Reduced Stigma and Increased Privacy

One of the most significant advantages of long-acting injectables is the reduction in the stigma associated with HIV. Without the daily ritual of taking pills, individuals can enjoy greater privacy about their health status. This can be especially empowering in environments where there is a high level of stigma surrounding HIV.

Enhanced Efficacy and Safety Profiles

Long-acting injectables like Cabenuva have shown promising efficacy and safety profiles. By maintaining consistent medication levels in the body, they help keep the virus suppressed, reducing the chances of resistance and improving overall health outcomes.

Impact on Mental Health and Quality of Life

Living with HIV can take a toll on mental health. The shift from daily pills to long-acting injectables can alleviate the psychological burden and improve the overall quality of life. Patients report feeling freer and less encumbered by their treatment regimen, which has a positive impact on mental well-being.

The Freedom of Less Frequent Dosing

The infrequent dosing schedule of long-acting injectables offers a sense of freedom that daily medications can’t match. Patients can travel, work, and engage in social activities without the need to plan around taking medication. This opens up a new world of possibilities.

At Pathway To Better Health, we embrace the advancements in HIV treatment, including long-acting injectables, to provide the best care and support for our patients. If you’re considering switching to a long-acting injectable regimen or want to learn more about your options, reach out to us. Our team is dedicated to empowering you with the knowledge and care you need to manage your health on your terms.

How Do Long-acting Injectables Work?

Long-acting injectable (LA-Injectable) HIV treatments are a groundbreaking advancement in the management of HIV. Unlike traditional daily oral regimens, LA-Injectables provide a sustained release of medication over time, minimizing the need for frequent dosing and simplifying the lives of those living with HIV.

The Science Behind the Medication

LA-Injectable HIV treatments, such as Cabenuva, contain antiretroviral drugs that experts have modified to remain active in the body for longer durations. Healthcare providers administer these treatments via intramuscular injection, where they release slowly, ensuring therapeutic drug levels in the bloodstream and effectively suppressing the virus.

The Mechanism of Action Explained

The medications in LA-Injectable treatments work by inhibiting different stages of the HIV lifecycle. For instance, Cabenuva combines rilpivirine, which prevents the virus from making a DNA copy of itself, with cabotegravir, which stops the integration of viral DNA into the host’s genome. This dual action effectively halts the replication of HIV.

The Importance of Adherence to Treatment Schedule

Although LA-Injectables reduce the frequency of dosing, adherence to the injection schedule is crucial to maintain viral suppression. Missing doses can lead to suboptimal drug levels and potentially foster drug resistance and treatment failure.

Understanding the Injection Process

A healthcare provider administers LA-Injectable HIV treatments. Typically, they administer the injections in the buttocks, selecting this site for its capacity to accommodate the medication volume and its slow-release properties.

The Role of Healthcare Providers in Administration

Healthcare providers play a vital role in the administration of LA-Injectable treatments. They ensure proper injection technique, monitor for adverse reactions, and provide support and education to patients transitioning from oral medications to injectables.

Who Is Eligible for Long-acting Injectable HIV Treatment?

Not everyone living with HIV is a candidate for LA-Injectable treatments. Here are some considerations:

Assessing Patient Suitability

Patients need to be virologically suppressed on a stable antiretroviral regimen before transitioning to LA-Injectables. This means having an undetectable viral load on their current oral treatment.

The Criteria for Starting Long-acting Injectables

Eligibility criteria include being on a stable oral regimen without a history of treatment failure and having no known resistance to the drugs in the LA-Injectable.

Managing Expectations: What Patients Need to Know

Patients should have realistic expectations about the injection process, potential side effects, and the importance of adherence to their injection schedule.

The Importance of Comprehensive Health Evaluation

A thorough health evaluation is essential before starting LA-Injectables. This will ensure that the treatment is suitable and safe for the patient.

Transitioning from Oral Medications to Injectables

Transitioning from oral medications to injectables should be carefully managed to maintain viral suppression and prevent drug resistance.

The Future of HIV Treatment and Care

The evolution of HIV treatment continues to progress at an impressive pace:

Ongoing Research and Developments

Research into new drug formulations, combination therapies, and even potential cures is ongoing.

Potential Innovations on the Horizon

Innovations include even longer-acting formulations, multi-drug regimens in a single injection, and implantable devices for drug delivery.

The Role of Patient Feedback in Shaping Future Treatments

Patient experiences and feedback are invaluable in the development of new treatments that meet their needs and preferences.

Global Access and Availability Challenges

Ensuring that these advancements are accessible and affordable globally remains a challenge.

The Vision for a World Without HIV

The ultimate goal is to create a world where HIV is a manageable condition with minimal impact on the quality of life, or even better, where HIV has been eradicated.

Pathway To Better Health is committed to integrating these advancements into our practice, guaranteeing that our patients have access to the latest and most effective treatments.

If you are considering LA-injectable treatment or want to learn more about your options, contact us to schedule an appointment.

FAQ’s about Cabenuva for HIV Treatment

What is Cabenuva?

Cabenuva is a long-acting injectable treatment for adults with HIV. It consists of two antiretroviral medications: rilpivirine and cabotegravir. This treatment targets people who have an undetectable viral load on a stable antiretroviral regimen. Furthermore, individuals must have neither a history of treatment failure nor known nor suspected resistance to either rilpivirine or cabotegravir.

How often is Cabenuva administered?

Healthcare providers administer Cabenuva as an intramuscular injection once every two months after the initial month of treatment.

Who is eligible for Cabenuva?

Cabenuva is indicated for adults living with HIV who have achieved and can maintain viral suppression with their current medication. Before switching to Cabenuva, patients must be stable on a traditional oral regimen, with no history of treatment failure.

What are the benefits of using Cabenuva?

The benefits of Cabenuva include the convenience of every other month dosing. This can lead to better adherence and simplification of treatment routines. It also offers privacy and discretion, as it reduces the need for daily medication.

What are the side effects of Cabenuva?

As with any medication, there can be side effects. The most common side effects reported in clinical trials include injection site reactions, fever, fatigue, headache, musculoskeletal pain, nausea, sleep disorders, dizziness, and rash. It’s important to discuss potential side effects with your healthcare provider.

How will I know if my health insurance will cover Cabenuva?

The team at Pathway to Better Health will work with your health insurance company and the speciality pharmacy to determine if your insurance will cover the cost of Cabenuva. Most Medicaid and commercial insurance plans will cover Cabenuva. Additionally, Viiv, the pharmaceutical company manufacturing Cabenuva, operates a savings and assistance program for eligible patients. Click here to access the saving plan.

How can I start treatment with Cabenuva?

Interested in starting treatment with Cabenuva? Schedule an appointment with Pathway To Better Health here. They can assess your eligibility for the medication based on your current health, medical history, and specific needs.

Remember, while Cabenuva offers a new avenue for HIV treatment, it’s important to have a thorough discussion with a healthcare provider to understand if it is the right option for you. At Pathway To Better Health, our team is here to provide you with the information and support you need to make informed decisions about your HIV care.